Fundraising Fox

Lifeward

NASDAQ: LFWD

Marlborough, US · Incorporated in Israel · 1 known investors

Biotech

Founders & leadership

CR
Charles RemsbergExecutive Officer
LJ
Larry JasinskiExecutive Officer, Director
ML
Michael LawlessExecutive Officer
AA
Almog AdarExecutive Officer
JL
Jeannine LynchExecutive Officer
HL
Hadar LevyDirector
WM
William Mark GrantExecutive Officer, Director
OG
Ori GonExecutive Officer
OK
Ofir KorenExecutive Officer
YE
Yohanan EngelhardtDirector
PW
Peter WehrlyDirector
YI
Yasushi IchikiDirector

Investors · 1

SCP Vitalife PartnersreportedTel Aviv · $3M – $7Mvia Wayne B. Weisman · board

Reported raises · per SEC filings

Form D private placements
▶$11.2MraisedJul 2026 · 5 investors · Biotechnology
Rule 506(b)
Lifeward stock rises on $5.6M funding with milestone upside By Investing.comng.investing.com · Jul 2026Lifeward secures $5.6m in convertible notes financing By Investing.cominvesting.com · Jul 2026
Officers, directors & promoters on the filing
  • William Mark GrantExecutive Officer, Director
Amount sold
$11.2M
First sale
Jul 2026
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedApr 2026 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • William Mark GrantExecutive Officer, Director
Amount sold
$20M
First sale
Mar 2026
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randel RichnerDirector
  • Joseph TurkDirector
  • Charles RemsbergExecutive Officer
  • Larry JasinskiExecutive Officer, Director
  • Michael LawlessExecutive Officer
  • Almog AdarExecutive Officer
  • Jeannine LynchExecutive Officer
  • Michael SwinfordDirector
  • John William PoduskaDirector
  • Hadar LevyDirector
  • Robert J MarshallDirector
Offering amount
$5M
Amount sold
$5M
Sales commissions
$350K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jan 2025
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.3MraisedOct 2021 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne B. WeismanDirector
  • John William PoduskaDirector
  • Arik DanDirector
  • Larry JasinskiExecutive Officer, Director
  • Yasushi IchikiDirector
  • Randel RichnerDirector
  • Ori GonExecutive Officer
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
Offering amount
$16.3M
Amount sold
$16.3M
Sales commissions
$2.8M
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Sep 2021
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40MraisedFeb 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Randel RichnerDirector
  • Arik DanDirector
  • Yasushi IchikiDirector
  • John William PoduskaDirector
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
  • Ori GonExecutive Officer
  • Larry JasinskiExecutive Officer, Director
  • Wayne B. WeismanDirector
Offering amount
$40M
Amount sold
$40M
Sales commissions
$3.4M
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Feb 2021
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedDec 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Yohanan EngelhardtDirector
  • Arik DanDirector
  • Randel RichnerDirector
  • Yasushi IchikiDirector
  • Jeff DykanDirector
  • John William PoduskaDirector
  • Larry JasinskiExecutive Officer, Director
  • Ori GonExecutive Officer
  • Ofir KorenExecutive Officer
  • Wayne B. WeismanDirector
Offering amount
$8M
Amount sold
$8M
Sales commissions
$680K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Dec 2020
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJul 2020 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John William PoduskaDirector
  • Yasushi IchikiDirector
  • Ofir KorenExecutive Officer
  • Yohanan EngelhardtDirector
  • Jeff DykanDirector
  • Larry JasinskiExecutive Officer, Director
  • Arik DanDirector
  • Wayne B. WeismanDirector
  • Ori GonExecutive Officer
Offering amount
$8.8M
Amount sold
$4.5M
Sales commissions
$765K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jul 2020
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.8MofferedJun 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Larry JasinskiExecutive Officer, Director
  • Ori GonExecutive Officer
  • Ofir KorenExecutive Officer
  • Jeff DykanDirector
  • Wayne B. WeismanDirector
  • John William PoduskaDirector
  • Yohanan EngelhardtDirector
  • Peter WehrlyDirector
  • Yasushi IchikiDirector
  • Arik DanDirector
  • Chunlin (Allen) HanDirector
Offering amount
$10.8M
Sales commissions
$922.2K
Placement agents
H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC, H.C. Wainwright & Co., LLC
First sale
Jun 2019
Incorporated
Other, Israel
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news